Optimized RD1- and RD2-derived peptide pools for detecting T-Cell responses to Mycobacterium tuberculosis antigens
BMC Microbiology · 21.11.2026
DOI: 10.1186/s12866-026-05914-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Microbiology, online erschienen am 21.11.2026. Verfasst von Qi Ouyang und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Interferon-gamma release assays (IGRAs) using RD1 antigens of Mycobacterium tuberculosis ( M.tb ) are widely used for tuberculosis (TB) infection screening and vaccine evaluation but have limited sensitivity in high-burden settings. RD2 antigens may broaden the range of detectable antigen responses. This study aimed to develop and assess optimized RD1- and RD2-derived peptide pools for detecting T-cell responses to M.tb antigens.
Methods
Recombinant RD1 and RD2 proteins, including RD1(rEC), RD2(rCM), MPT64, and CFP21, were prepared. Their immunogenicity was assessed using IFN-γ ELISPOT and intracellular cytokine staining in M.tb -immunized mice, and IFN-γ ELISPOT in PBMCs from patients with latent TB infection (LTBI) and PFMCs from patients with tuberculous pleural effusion (TPE). LTBI was operationally defined by a positive T-SPOT.TB result in the absence of evidence of active TB. HLA-binding prediction guided the design of overlapping peptide libraries for ESAT-6, CFP10, MPT64, and CFP21. Immunoreactive peptides identified by single-peptide ELISPOT screening in LTBI PBMCs and TPE PFMCs were assembled into optimized RD1 and RD2 peptide pools and evaluated by IFN-γ ELISPOT and IFNG RT-qPCR in LTBI PBMCs.
Results
The four recombinant antigens RD1(rEC), RD2(rCM), MPT64, and CFP21 induced significantly stronger IFN-γ responses in splenocytes from heat-inactivated M.tb -immunized mice than in PBS- or BCG-immunized controls, involving both CD4⁺ and CD8⁺ T cells. In human samples, RD2(rCM) elicited broader T cell responses than MPT64 or CFP21 alone, and combining RD1 and RD2 antigens further expanded the response coverage. HLA-binding prediction guided library design and single-peptide ELISPOT in LTBI PBMCs and TPE PFMCs identified immunoreactive peptide regions within ESAT-6, CFP10, MPT64, and CFP21, and ten RD1 and eight RD2 peptides were selected for the optimized pools. RD1 pool-2 and RD2 pool-2 were ELISPOT-positive in 12/12 and 7/12 LTBI participants, respectively. In a separate cohort, peptide-pool stimulation induced significantly higher IFNG expression in LTBI PBMCs ( n = 6) than in healthy-control PBMCs ( n = 5).
Conclusions
The RD1- and RD2-derived peptide pools elicited antigen-responsive IFN-γ production and IFNG transcription in the evaluated cohorts. These findings support the proof of concept for detecting responses to the selected antigens; however, larger, independent cohorts are needed to assess diagnostic performance.
Trial registration
Not applicable.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Ouyang, Q., Xu, X., Cao, J., Wang, X., Dan, P., Yao, Y., Yao, X., Liu, H., Huang, C., Zhang, D., & Fan, X. (2026). Optimized RD1- and RD2-derived peptide pools for detecting T-Cell responses to Mycobacterium tuberculosis antigens. BMC Microbiology. https://doi.org/10.1186/s12866-026-05914-8
Vancouver
Ouyang Q, Xu X, Cao J, Wang X, Dan P, Yao Y, et al. Optimized RD1- and RD2-derived peptide pools for detecting T-Cell responses to Mycobacterium tuberculosis antigens. BMC Microbiology. 2026. doi:10.1186/s12866-026-05914-8
BibTeX
@article{Ouyang2026,
author = {Ouyang, Qi and Xu, Xinyue and Cao, Jinge and Wang, Xingxing and Dan, Peihang and Yao, Yinlong and Yao, Xuanyu and Liu, Hongbo and Huang, Chaolin and Zhang, Dingyu and Fan, Xionglin},
title = {Optimized RD1- and RD2-derived peptide pools for detecting T-Cell responses to Mycobacterium tuberculosis antigens},
journal = {BMC Microbiology},
year = {2026},
doi = {10.1186/s12866-026-05914-8}
}
EUVIMED